Log in

Start Your Membership Now

On March 26, 2019, the Kentucky Cabinet for Health and Family Services (CHFS), Department for Medicaid Services (DMS) announced plans to file a Medicaid State Plan Amendment (SPA) to add coverage of methadone. CHFS intends to file the SPA by May 1, 2019. The changes would become effective on July 1, 2019. Currently, DMS covers buprenorphine and Vivitrol. After the SPA goes into effect, any Medicaid beneficiary with a diagnosis of opioid use disorder will be able to access medication assisted treatment (MAT) via buprenorphine, Vivitrol, or methadone.

In the notice, “Kentucky Medicaid Program Public Notice: Substance Use Disorder,” CHFS . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: